EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSECRG00000016432
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSECRG00000010296
Gene Symbol: RPSA
3 Cross references
519 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSECRG00000018347
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSECRG00000014863
Gene Symbol: RPLP1
3 Cross references
387 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSECRG00000010197
Gene Symbol: LOC114660611
3 Cross references
192 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3

Ensembl ID : ENSECRG00000004836
Gene Symbol: LOC114659488
3 Cross references
196 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSECRG00000009998
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSECRG00000015538
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
460 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSECRG00000007911
Gene Symbol: SIGMAR1
3 Cross references
206 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSECRG00000007786
Gene Symbol: SIRT1
3 Cross references
159 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSECRG00000002687
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Alpha Subunit

Ensembl ID : ENSECRG00000012029
Gene Symbol: SCNN1A
2 Cross references
153 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).